11 Dec 2016 AXON’s Alzheimer Tau Vaccine Phase 1 Study Results Published in Lancet Neurology
09 Dec 2016 NW Bio Provides Update About Phase 3 Trial Of DCVax®-L for Newly Diagnosed Glioblastoma Multiforme Brain Cancer
09 Dec 2016 Valneva Receives FDA and European Approvals to Start Clinical Testing of Lyme Disease Vaccine Candidate
08 Dec 2016 Selecta Presents Phase 1 Clinical Data for Lead Product Candidate, SEL-212, in Patients with Hyperuricemia at 11th Annual IMVAC Summit
08 Dec 2016 Transgene: UC Davis to Conduct Phase 2 Trial of the Combination of TG4010 with Opdivo® (nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)
07 Dec 2016 ISA Pharmaceuticals Advances Personalized Cancer Treatment
06 Dec 2016 Boston Biomedical Announces First Clinical Data for Investigational WT1 Cancer Peptide Vaccine, DSP-7888, at ASH Annual Meeting & Exposition
06 Dec 2016 Heat Biologics Presents Topline HS-110/Nivolumab Combination Lung Cancer Results
01 Dec 2016 VAXIMM Presents Preclinical Data on Three Novel Oral T-Cell Cancer Immunotherapies at EORTC-NCI-AACR Symposium
29 Nov 2016 BiondVax Phase 2b Trial Preliminary Safety Results: The Universal Flu Vaccine Candidate is Safe and Well Tolerated
28 Nov 2016 OncoPep Announces Initiation of Phase 1b Clinical Trial of PVX-410 in Smoldering Multiple Myeloma and Upcoming Presentation of Positive Results from Phase 1/2a Clinical Trial at ASH
28 Nov 2016 OncoPep Announces Initiation of Phase 1b Clinical Trial of PVX-410 in Triple Negative Breast Cancer
28 Nov 2016 Aimmune Therapeutics Completes Global Enrollment of Phase 3 PALISADE Trial of AR101 for the Treatment of Peanut Allergy
22 Nov 2016 Yisheng Biopharma Announces Completion of Phase I Clinical Study of a Novel Hepatitis B Vaccine with PIKA Adjuvant
21 Nov 2016 Partial Clinical Hold Lifted and Enrollment Resumes for Aduro Biotech LADD Clinical Trials
21 Nov 2016 ImmunoCellular Therapeutics Reports Updated Immune Monitoring Data from ICT-107 Phase 2 Trial in Newly Diagnosed Glioblastoma at the Society for Neuro-Oncology Annual Meeting 2016
19 Nov 2016 GlobeImmune Announces Updates
17 Nov 2016 Neon Therapeutics Announces First Patient Enrolled in Inaugural Clinical Trial for Personalized Cancer Vaccine NEO-PV-01
15 Nov 2016 Dynavax Receives Complete Response Letter from U.S. Food and Drug Administration for Biologics License Application for HEPLISAV-B
15 Nov 2016 Transgene Presents Preclinical Results of TG1050, an HBV-targeted Immunotherapy, at AASLD 2016 Liver Meeting
14 Nov 2016 CEL-SCI Reports Preclinical Data Showing LEAPS Vaccine is Successful in Treating Rheumatoid Arthritis
14 Nov 2016 Inovio’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and Peripheral Blood in Patients with HPV-Associated Head and Neck Cancer
14 Nov 2016 Aduro Biotech Highlights Positive Clinical Results from Second Cohort of Phase 1b Mesothelioma Clinical Trial
10 Nov 2016 Inovio Pharmaceuticals Zika Vaccine Protects Animals from Infection, Brain Damage and Death
08 Nov 2016 Madison Vaccines Says Promising Early Data on the Combination of Its Lead Prostate Cancer Vaccine with a PD-1 Inhibitor Will Be Presented at Major Medical Meeting Nov. 11th

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing